Literature DB >> 6744661

Surface proteins of the human eosinophil. II. Effects of Schistosoma mansoni larvae on eosinophil surface proteins.

K J Thorne, B A Richardson, A E Butterworth.   

Abstract

Incubation of eosinophils with schistosoma of Schistosoma mansoni in vitro induces changes in the eosinophil membrane. Cell surface proteins were blocked with unlabelled iodide and then, after incubation with schistosomula, newly accessible proteins were detected by lactoperoxidase catalysed iodination with radioactive iodide. Normal turnover restores several proteins to the eosinophil surface, but the schistosomula specifically induced the appearance of a protein of mol. wt 18K. This protein has previously been detected when eosinophils interact with antibody coated agar layers. Soluble factors released by schistosomula induced the appearance of enhanced levels of 16 and 18K proteins. It has previously been shown that proteins involved in binding of eosinophils to IgG coated antigen coupled cellulose have mol. wts of 16K and 18K.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6744661      PMCID: PMC1536008     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Eosinophils as mediators of antibody-dependent damage to schistosomula.

Authors:  A E Butterworth; R F Sturrock; V Houba; A A Mahmoud; A Sher; P H Rees
Journal:  Nature       Date:  1975-08-28       Impact factor: 49.962

2.  Studies on blood eosinophils. I. Patients with a transient eosinophilia.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  Studies on blood eosinophils. II. Patients with Löffler's cardiomyopathy.

Authors:  C J Spry; P C Tai
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

4.  A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni.

Authors:  M A Vadas; J R David; A Butterworth; N T Pisani; T A Siongok
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

5.  Surface proteins on schistosomula and cercariae of Schistosoma mansoni.

Authors:  R Ramasamy
Journal:  Int J Parasitol       Date:  1979-12       Impact factor: 3.981

6.  Phagocytic properties of isolated human eosinophils.

Authors:  W H Grover; H H Winkler; D E Normansell
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

7.  Rat mast cell-eosinophil interaction in antibody-dependent eosinophil cytotoxicity to Schistosoma mansoni schistosomula.

Authors:  M Capron; J Rousseaux; C Mazingue; H Bazin; A Capron
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

8.  Schistosoma mansoni in the Kenyan baboon (Papio anubis): the development and predictability of resistance to homologous challenge.

Authors:  R F Sturrock; A E Butterworth; V Houba; S D Karamsadkar; R Kimani
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

9.  Phagocytosis and killing of Trypanosoma dionisii by human neutrophils, eosinophils and monocytes.

Authors:  K J Thorne; A M Glauert; R J Svvennsen; D Franks
Journal:  Parasitology       Date:  1979-12       Impact factor: 3.234

10.  Surface proteins of the human eosinophil. I. Isolation of eosinophil IgG binding proteins.

Authors:  K J Thorne; D Franks
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

View more
  3 in total

Review 1.  Eosinophils. Assays and interpretation.

Authors:  D E Maddox
Journal:  Clin Rev Allergy       Date:  1988

2.  Plasma membrane antigens on light density and activated human blood eosinophils.

Authors:  P C Tai; D M Bakes; J R Barkans; C J Spry
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

3.  Monoclonal antibodies to human eosinophil plasma membrane antigens enhance the secretion of eosinophil cationic protein.

Authors:  P C Tai; M Capron; D M Bakes; J Barkans; C J Spry
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.